The Korea Journal of Herbology (대한본초학회지)

The Korea Association of Herbology (대한본초학회)
권호 표지
DOI QR코드

DOI QR Code

Protective effects of Smilacis Glabrae Rhizoma on acute pancreatitis

토복령(土茯苓) 물 추출물의 급성 췌장염 보호 효과

  • Kim, Myoung-Jin (Department of Herbology, School of Oriental Medicine, Wonkwang University) ;
  • Park, Sung-Joo (Department of Herbology, School of Oriental Medicine, Wonkwang University)
  • 김명진 (원광대학교 한의과대학 본초학교실) ;
  • 박성주 (원광대학교 한의과대학 본초학교실)
  • Received : 2018.02.10
  • Accepted : 2018.03.15
  • Published : 2018.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Smilacis Glabrae Rhizoma (SGR) has been used in traditional medicine for treating diseases related to inflammation and cancer. However, the protective effect of SGR has not been reported in the study of acute pancreatitis (AP). Therefore, this study was performed to evaluate the protective effects of SGR water extract on cerulein-induced AP. Methods : AP was induced by intraperitoneal injection of supramaximal concentrations of stable cholecystokinin analogue cerulein ($50{\mu}g/kg$) 6 times at intervals of one hour in mice. SGR water extract (0.01, 0.05, or 0.1 g/kg) was administrated intraperitoneally 1 h prior to the first injection of cerulein. The mice were sacrificed at 6 h after the final injection of cerulein. Pancreas and lung were rapidly removed for histochemical examination and myeloperoxidase (MPO) assay. In addition, polymerase chain reaction (PCR) was performed to examine mRNA levels of proinflammatory cytokines such as interleukin(IL)-6, $IL-1{\beta}$ and Tumor necrosis $factor(TNF)-{\alpha}$. Results : Administration of SGR water extract significantly inhibited pancreatic weight to body weight ratio. In addition, SGR treatment inhibited the histological damages and increase of MPO activity in both pancreas and lung during AP. Also, mRNA levels of IL-6 but not $IL-1{\beta}$and $TNF-{\alpha}$ were inhibited by SGR water extract against AP. Conclusion : Our results revealed that pre-treatment of SGR water extract reduces the severity of cerulein-induced AP. Therefore, this study suggest that SGR could be used as a drug or agent to prevent AP.

Keywords

References

  1. Kingsnorth A, O'Reilly D. Acute pancreatitis. Br Med J. 2006;332:1072-6. https://doi.org/10.1136/bmj.332.7549.1072
  2. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-210. https://doi.org/10.1056/NEJM199404283301706
  3. Zhou MT, Chen CS, Chen BC, Zhang QY, Andersson R. Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol. 2010;16(17):2094-9. https://doi.org/10.3748/wjg.v16.i17.2094
  4. Andersson R, Andersson B, Haraldsen P, Drewsen G, Eckerwall G. Incidence, management and recurrence rate of acute pancreatitis. Scand J Gastroenterol. 2004; 39(9):891-4. https://doi.org/10.1080/00365520410007061
  5. Beger HG, Rau B, Isenmann R. Natural history of necrotizing pancreatitis. Pancreatology. 2003;3(2): 93-101. https://doi.org/10.1159/000070076
  6. Yoon YK, Ji JH, Mun BS. Hypertriglyceridemiainduced pancreatitis. Korean J Gastroenterol. 2008; 51:309-13.
  7. Wang GJ, Gao CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: Etiology and common pathogenesis. World J Gastroenterol. 2009;15:1427-30. https://doi.org/10.3748/wjg.15.1427
  8. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med. 1999;340:1412-7. https://doi.org/10.1056/NEJM199905063401807
  9. Ho HS, Frey CF. Gastrointestinal and pancreatic complications associated with severe pancreatitis. Arch Surg. 1995;130:817-22. https://doi.org/10.1001/archsurg.1995.01430080019002
  10. Kota SK, Kota SK, Jammula S, Krishna SV, Modi KD. Hypertriglyceridemia-induced recurrent acute pancreatitis: A case-based review. Indian J Endocrinol Metab. 2012;16:141-3. https://doi.org/10.4103/2230-8210.91211
  11. Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996;20:177-84. https://doi.org/10.1007/BF02803766
  12. Lee HS. Experimental animal models of pancreatic disease. Kor J Gastroenterol Seminar. 2002;144-51.
  13. Park JA, Jin KS, Kwon HJ, Kim BW. The Anti-Obesity Effect of Smilax china Extract. Korean J. Microbiol. Biotechnol. 2014;42(4):354-360. https://doi.org/10.4014/kjmb.1407.07009
  14. Oh SW, Kim BW. Anti-inflammatory Effects of Smilacis Glabrae Rhizoma in Raw 264.7 Cells. Korean J. Orient.Int. Med. 2009;30(2):288-297.
  15. Ntambi JM, Kim YC. Adipocyte differentiation and gene expression. J. Nutr. 2000;130:3122-3126. https://doi.org/10.1093/jn/130.12.3122S
  16. Rosen ED, Hsu CH, Wang X, Sakai X, Freeman MW, Gonzalez FJ, et al. $C/EBP{\alpha}$ induces adipogenesis through PPAR: a unified pathway. Genes Dev. 2001 ;16:22-26.
  17. Shu XS, Gao ZH, Yang XL. The anti-inflammation effects of Smilax china ethylacetate extract in rats and mice. Zhongguo Zhong Yao Za Zhi. 2006;31(3) :239-43.
  18. Lee SE, Ju EM, Kim JH. Free radical scavenging and antioxidant enzyme fortifying activities of extracts from Smilax china root. Exp Mol Med. 2001;33(4):263-8. https://doi.org/10.1038/emm.2001.43
  19. Li YL, Gan GP, Zhang HZ, Wu HZ, Li CL, Huang YP, et al. A flavonoid glycoside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines. J. Ethnopharmacol. 2007;113:115-124. https://doi.org/10.1016/j.jep.2007.05.016
  20. Xu W, Liu J, Li C, Wu HZ, Liu YW. Kaempferol-7-Obeta-D-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner. Cancer Lett. 2008;264:229-240. https://doi.org/10.1016/j.canlet.2008.01.044
  21. Nissen SE, Wolski K, Topol EJ. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA. 2005;294:2581-6. https://doi.org/10.1001/jama.294.20.joc50147
  22. Rau BM, Kruger CM, Schilling MK. Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications. Rocz Akad Med Bialymst. 2005;50:106-15.
  23. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2-3):132-44. https://doi.org/10.1159/000085265
  24. Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg. 2000;232(5):619-26. https://doi.org/10.1097/00000658-200011000-00001
  25. Oruc N, Ozutemiz AO, Yukselen V, Nart D, Celik HA, Yuce G, Batur Y. Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas. 2004;28(1): e1-8. https://doi.org/10.1097/00006676-200401000-00020
  26. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, Axelsen M. Glycemic index: Overview of implications in health and disease. Am J clin Nutr. 2002;76(1):266S-73S. https://doi.org/10.1093/ajcn/76.1.266S
  27. Lee H, Lin JY. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutat Res. 1988;204(2):229-34. https://doi.org/10.1016/0165-1218(88)90093-6
  28. Park IH, Song JH, Kwon HD, Lee WK. Antimicrobial Activity and Composition of Extract from Smilax china Root. J Korean Soc. Food Sci. Nutr. 1998; 27(4):574-84.
  29. Kim SJ, Cho CS, Kim CJ. The Effect of Smilacis Glabrae Rhizoma on Rats with Gout induced by Monosodium Urate. Journal of Haehwa Medicine. 2008;17(1):95-104
  30. Granger J, Remick D. Acute pancreatitis : models, markers, and mediators. Shock. 2005;24(1):45-51. https://doi.org/10.1097/01.shk.0000191413.94461.b0
  31. Panteghini M, Pagani F, bonora R. Clinical and analytical evaluation of a continuous enzymatic methods for measuring pancreatic lipase activity. Clin chem. 1993;39(2):304-8.
  32. Colgan SP, Ehrentraut SF, Glover LE, Kominsky DJ, Campbell EL. Contributions of neutrophils to resolution of mucosal inflammation. Immunol Res. 2013;55(1-3):75-82. https://doi.org/10.1007/s12026-012-8350-2
  33. Interiano B, Stuard ID, Hyde RW. Acute respiratory distress syndrome in pancreatitis. Ann Int Med. 1972;77:923-6. https://doi.org/10.7326/0003-4819-77-6-923
  34. Guice KS, Oldham KT, Johnson KJ, Kunkel RG, Morganroth ML, Ward PA. Pancreatitits-induced acute lung injury, an ARDS model. Ann Surg. 1988 ;208(1):71-7. https://doi.org/10.1097/00000658-198807000-00010
  35. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology. 1996; 110(2):639-4201. https://doi.org/10.1053/gast.1996.v110.agast960639
  36. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000;47(4):546-52. https://doi.org/10.1136/gut.47.4.546
  37. Eubanks JW 3rd, Sabek O, Kotb M, Gaber LW, Henry J, Hijiya N, Britt LG, Gaber AO, Goyert SM. Acute pancreatitis induces cytokine production in endotoxin-resistant mice. Ann Surg. 1998;227(6) :904-11. https://doi.org/10.1097/00000658-199806000-00014
  38. Malmstrom ML, Hansen MB, Andersen AM, Ersboll AK, Nielsen OH, Jorgensen LN, Novovic S. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas. 2012;41(2):271-7. https://doi.org/10.1097/MPA.0b013e3182240552
  39. Perides G, Weiss ER, Michael ES, Laukkarinen JM, Duffield JS, Steer ML. TNF-alpha-dependent regulation of acute pancreatitis severity by Ly-6C (hi) monocytes in mice. J Biol Chem. 2011;286(15) :13327-35. https://doi.org/10.1074/jbc.M111.218388